HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

Go back to HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
BIOTELEMETRY (NASDAQ: BEAT) Delayed: 0.43 +0.01 (2.38%)
Previous Close $0.42    52 Week High $21.68 
Open $0.42    52 Week Low $8.74 
Day High $0.43    P/E N/A 
Day Low $0.40    EPS $-0.46 
Volume 491,542